Evaluating Reduced Dose RUTF and Alternative Supplement Protocols for Managing Acute Malnutrition in Children 6 to 59 Months in Burkina Faso
Led by Institut de Recherche en Sciences de la Sante, Burkina Faso · Updated on 2026-10-23
3521
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating an alternative approach to manage acute malnutrition in children aged 6 to 59 months in Burkina Faso. The study compares the use of ready-to-use therapeutic food RUTF instead of ready-to-use supplementary food RUSF for moderate acute malnutrition MAM, and reduced-dose RUTF versus standard-dose RUTF for severe acute malnutrition SAM. The trial also explores the effects of this protocol on cost-effectiveness, psychomotor development, growth, and relapse rates.
Children diagnosed with MAM or SAM will be randomly assigned to different treatment groups. Those with MAM receive either RUTF or RUSF daily according to weight for up to 12 weeks. Children with SAM receive either reduced or standard doses of RUTF until programmatic recovery, also for a maximum of 12 weeks. Following recovery, participants are monitored monthly for up to 3 months to assess sustained recovery.
Participants visit the health center weekly for SAM and biweekly for MAM during treatment. At each visit, growth measurements are taken and caregivers complete questionnaires about health and supplement use. Adherence is checked by collecting empty supplement packaging, and any difficulties or adverse events are recorded. Psychomotor development is assessed in a subset of children. The main outcomes measured include programmatic recovery rates up to 12 weeks and sustained recovery at 3 months post-treatment.
CONDITIONS
Brief Title
Effectiveness of an Alternative Protocol in the Management of Acute Malnutrition
Research Team
H
Hermann Biènou LANOU, MD., PhD
S
Seni KOUANDA, MD., PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Institut de Recherche en Sciences de la Sante, Burkina Faso
Lead Sponsor
Bill and Melinda Gates Foundation
Collaborating Sponsor
Who Can Participate
Age: 6Months - 59Months
All Genders
Eligibility Criteria
You may qualify if you...
Children aged 6 to 59 months
For moderate acute malnutrition (MAM): specific arm circumference and weight-for-length criteria as defined by MUAC and WLZ measurements
For severe acute malnutrition (SAM): MUAC less than 115 mm or weight-for-length Z-score less than -3 SD
Parents agree to attend weekly visits for SAM or biweekly visits for MAM until program discharge
Parents agree to monthly follow-up visits for up to 3 months after recovery
You will not qualify if you...
Failure of appetite test
Medical complications needing hospital treatment
Presence of congenital anomalies or chronic diseases affecting growth or infection risk
Presence of bilateral oedema
History of allergies to peanuts, milk, or soya
Relapse from MAM treatment or transfer from SAM treatment
Participation in a nutrition program within the last 2 months
Living outside the study area
Caregivers unable to comply with study requirements due to medical or other conditions
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 12 weeks
Participants receive daily supplementation with ready-to-use therapeutic or supplementary food according to their assigned group. Children with severe acute malnutrition visit weekly, and those with moderate acute malnutrition visit biweekly for up to 12 weeks until recovery.
Weekly visits for SAM; biweekly visits for MAM
Follow-up
Duration - Up to 3 months
After recovery, participants are monitored monthly for up to 3 months to assess sustained recovery and track any relapses or health changes.
Monthly visits
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
5
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
New approach to simplifying and optimising acute malnutrition treatment in children aged 6-59 months: the OptiMA single-arm proof-of-concept trial in Burkina Faso.
Malian children with moderate acute malnutrition who are treated with lipid-based dietary supplements have greater weight gains and recovery rates than those treated with locally produced cereal-legume products: a community-based, cluster-randomized trial.
Robert S Ackatia-Armah, Christine M McDonald, Seydou Doumbia...
Treatment of moderate acute malnutrition with ready-to-use supplementary food results in higher overall recovery rates compared with a corn-soya blend in children in southern Ethiopia: an operations research trial.
Crystal Karakochuk, Tina van den Briel, Derek Stephens...
Effectiveness of ready-to-use therapeutic food compared to a corn/soy-blend-based pre-mix for the treatment of childhood moderate acute malnutrition in Niger.
Fabienne Nackers, France Broillet, Diakité Oumarou...
Associations of suboptimal growth with all-cause and cause-specific mortality in children under five years: a pooled analysis of ten prospective studies.
Ibironke Olofin, Christine M McDonald, Majid Ezzati...
A novel fortified blended flour, corn-soy blend "plus-plus," is not inferior to lipid-based ready-to-use supplementary foods for the treatment of moderate acute malnutrition in Malawian children.
The effect of multiple anthropometric deficits on child mortality: meta-analysis of individual data in 10 prospective studies from developing countries.
Christine M McDonald, Ibironke Olofin, Seth Flaxman...